
2026 US Cholesterol Guidelines Shift to Personalized, Early-Intervention Strategy
The American Heart Association and American College of Cardiology released updated dyslipidemia guidelines in March 2026, replacing the 2018 version. The new rules emphasize earlier screening and more aggressive, personalized treatment to reduce lifetime cardiovascular risk. Key changes include universal screening for lipoprotein(a), the use of new biomarkers like apolipoprotein B, and the adoption of the PREVENT-ASCVD risk calculator. Clinicians are now encouraged to use coronary artery calcium scans and specific lifestyle interventions to tailor care to individual patient profiles.





